147 related articles for article (PubMed ID: 10971054)
1. Mycosis fungoides: review of epidemiological observations.
Morales Suárez-Varela MM; Llopis González A; Marquina Vila A; Bell J
Dermatology; 2000; 201(1):21-8. PubMed ID: 10971054
[TBL] [Abstract][Full Text] [Related]
2. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
[TBL] [Abstract][Full Text] [Related]
3. Occupational mycosis fungoides - a case series.
Slodownik D; Moshe S; Sprecher E; Goldberg I
Int J Dermatol; 2017 Jul; 56(7):733-737. PubMed ID: 28255994
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of mycosis fungoides.
Weinstock MA
Semin Dermatol; 1994 Sep; 13(3):154-9. PubMed ID: 7986682
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous lymphomas and association to sex hormones.
Wohl Y; Golan H; Brenner S
Skinmed; 2003; 2(5):312-5. PubMed ID: 14673266
[TBL] [Abstract][Full Text] [Related]
6. A case-control study of clinicopathologic features, prognosis, and therapeutic responses in patients with granulomatous mycosis fungoides.
Li JY; Pulitzer MP; Myskowski PL; Dusza SW; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2013 Sep; 69(3):366-74. PubMed ID: 23685027
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
8. ALK Expression is a Rare Finding in Mycosis Fungoides.
Covington M; Cassarino D; Abdulla F
Am J Dermatopathol; 2017 May; 39(5):342-343. PubMed ID: 28426485
[TBL] [Abstract][Full Text] [Related]
9. Mycosis fungoides in the pediatric population: report from an international Childhood Registry of Cutaneous Lymphoma.
Pope E; Weitzman S; Ngan B; Walsh S; Morel K; Williams J; Stein S; Garzon M; Knobler E; Lieber C; Turchan K; Wargon O; Tsuchiya A
J Cutan Med Surg; 2010; 14(1):1-6. PubMed ID: 20128983
[TBL] [Abstract][Full Text] [Related]
10. Mycosis fungoides in Norway 1960-80. A retrospective study.
McFadden N; Nyfors A; Tanum G; Granholt A; Helme P; Kavli G
Acta Derm Venereol Suppl (Stockh); 1983; 109():1-13. PubMed ID: 6589937
[TBL] [Abstract][Full Text] [Related]
11. Occupational exposures and mycosis fungoides. A European multicentre case-control study (Europe).
Morales-Suárez-Varela MM; Olsen J; Johansen P; Kaerlev L; Guénel P; Arveux P; Wingren G; Hardell L; Ahrens W; Stang A; Llopis A; Merletti F; Aurrekoetxea JJ; Masala G
Cancer Causes Control; 2005 Dec; 16(10):1253-9. PubMed ID: 16215876
[TBL] [Abstract][Full Text] [Related]
12. Occupational risk factors for mycosis fungoides: a European multicenter case-control study.
Morales-Suárez-Varela MM; Olsen J; Johansen P; Kaerlev L; Guénel P; Arveux P; Wingren G; Hardell L; Ahrens W; Stang A; Llopis A; Merletti F; Aurrekoetxea JJ; Masala G
J Occup Environ Med; 2004 Mar; 46(3):205-11. PubMed ID: 15091282
[TBL] [Abstract][Full Text] [Related]
13. [Papular mycosis fungoides].
Brajon D; Bonnet N; Dales JP; Berbis P
Ann Dermatol Venereol; 2013; 140(6-7):455-8. PubMed ID: 23773745
[TBL] [Abstract][Full Text] [Related]
14. A retrospective study of the probability of the evolution of parapsoriasis en plaques into mycosis fungoides.
Väkevä L; Sarna S; Vaalasti A; Pukkala E; Kariniemi AL; Ranki A
Acta Derm Venereol; 2005; 85(4):318-23. PubMed ID: 16191852
[TBL] [Abstract][Full Text] [Related]
15. Incidence rate of mycosis fungoides in Isfahan (Iran).
Salehi M; Azimi Z; Fatemi F; Rajabi P; Kazemi M; Amini G
J Dermatol; 2010 Aug; 37(8):703-7. PubMed ID: 20649711
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis.
Goyal A; O'Leary D; Goyal K; Rubin N; Bohjanen K; Hordinsky M; Chen ST; Pongas G; Duncan LM; Lazaryan A
J Am Acad Dermatol; 2020 Aug; 83(2):404-411. PubMed ID: 31374302
[TBL] [Abstract][Full Text] [Related]
17. Review of contemporaneous mycosis fungoides and B-cell malignancy at Mayo Clinic.
Herro E; Dicaudo DJ; Davis MD; Weaver AL; Swanson DL
J Am Acad Dermatol; 2009 Aug; 61(2):271-5. PubMed ID: 19481294
[TBL] [Abstract][Full Text] [Related]
18. Mycosis fungoides--analysis of the duration of disease stages in patients who progress and the time point of high-grade transformation.
Kamarashev J; Theler B; Dummer R; Burg G
Int J Dermatol; 2007 Sep; 46(9):930-5. PubMed ID: 17822495
[TBL] [Abstract][Full Text] [Related]
19. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
20. Papular mycosis fungoides: two new cases of a recently described clinicopathological variant of early mycosis fungoides.
Martorell-Calatayud A; Botella-Estrada R; Sanmartín-Jimenez O; Requena C; Guillén-Barona C; Sangüeza OP
J Cutan Pathol; 2010 Mar; 37(3):330-5. PubMed ID: 19737334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
